Cantor Fitzgerald acquired a new stake in Cantor Equity Partners III on June 6, 2026.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald acquired a new stake in Cantor Equity Partners III on June 6, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Highbridge Capital Management
alternative investment management firm
Nothing else this week.
Related events
- Cantor Fitzgerald restated an overweight rating on shares, while J. Goldman & Co LP purchased a new stake in Annexon. Disclosure was made to the Securities and Exchange Commission.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald provided research reports on Cabaletta Bio, a company whose stock trades on Nasdaq.
- Cantor Fitzgerald disclosed a stock transaction involving Sonida Senior Living, Inc. in a legal filing on August 1, 2026.
- Both Cantor Fitzgerald and Oppenheimer Holdings began covering Five Below stock.